Common use of Non-Disclosure and Use of Evaluation Material Clause in Contracts

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, to any third party other than its Representatives (as defined below), without the prior written consent of the Company. (b) Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein (to the extent not prohibited by law) so as to enable the Company, at its sole expense to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s efforts to obtain a protective order. (c) Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractors, attorneys, lenders and affiliates (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential Transaction, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed in writing between Broker, Reviewer and/or Reviewer’s Agent.

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, to any third party other than its Representatives (as defined below), without the prior written consent of the Company. (b) Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein (to the extent not prohibited by law) so as to enable the Company, at its sole expense to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s efforts to obtain a protective order. (c) Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractors, attorneys, lenders and affiliates (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential Transaction, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed in writing between Broker, Reviewer and/or Reviewer’s Agent.

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, Material to any third party other than its Representatives (as defined below), without the prior written consent of the Company. (b) Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein above (to the extent not prohibited by law) so as to enable the Company, at its sole expense expense, to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s efforts to obtain a protective order. (c) Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractorsattorneys and affiliates (including, without limitation, attorneys, lenders accountants, consultants and affiliates financial advisors) (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential TransactionPurpose, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement. For the avoidance of doubt, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed approved by the Company in writing between Brokerwriting, Reviewer and/or Reviewer’s AgentRepresentatives shall not include financing or capital sources of any kind, whether debt, equity or otherwise.

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, Material to any third party other than its Representatives (as defined below), without the prior written consent of the Company. (b) . Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein above (to the extent not prohibited by law) so as to enable the Company, at its sole expense expense, to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s efforts to obtain a protective order. (c) . Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractorsattorneys and affiliates (including, without limitation, attorneys, lenders accountants, consultants and affiliates financial advisors) (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential TransactionPurpose, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement. For the avoidance of doubt, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed approved by the Company in writing between Brokerwriting, Reviewer and/or Reviewer’s AgentRepresentatives shall not include financing or capital sources of any kind, whether debt, equity or otherwise.

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, to any third party other than its Representatives (as defined below), without the prior written consent of the Company. (b) Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein (to the extent not prohibited by law) so as to enable the Company, at its sole expense to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s its efforts to obtain a protective order. (c) Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractors, attorneys, lenders affiliates, lenders, investors, business partners and affiliates prospective purchasers of the Asset (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential Transactionpurchase transaction, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed in writing between Broker, Reviewer and/or Reviewer’s Agent.

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, to any third party other than its Representatives (as defined below), without the prior written consent of the Company.. GA Confidentiality Agreement Form 1 (b) Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein (to the extent not prohibited by law) so as to enable the Company, at its sole expense to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s efforts to obtain a protective order. (c) Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractors, attorneys, lenders and affiliates (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential Transaction, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed in writing between Broker, Reviewer and/or Reviewer’s Agent.

Non-Disclosure and Use of Evaluation Material. (a) The Reviewer agrees that, except as set forth below, all Evaluation Material shall be used by the Reviewer solely for the purpose stated above. The Reviewer further agrees not to disclose any of the Evaluation Material, to any third party other than its Representatives (as defined below), without the prior written consent of the Company. (b) Any of the Evaluation Material that is required to be disclosed by law or by regulatory or judicial process may be disclosed without the Reviewer being in breach of its obligations under this Agreement. The Reviewer will provide the Company written notice at the address provided herein (to the extent not prohibited by law) so as to enable the Company, at its sole expense to take action to seek a protective order or other appropriate remedy to ensure confidential treatment of the Evaluation Material. The Reviewer agrees to furnish only that portion of the Evaluation Material as is legally required and agrees to cooperate with the Company on a reasonable basis in the Company’s its efforts to obtain a protective order. (c) Notwithstanding the foregoing, the Reviewer may disclose the Evaluation Material to its directors, officers, employees, agents, contractors, attorneys, lenders lenders, accountants, investors, financial advisors and affiliates (collectively, “Representatives”) who need to know such information for purposes of evaluating the potential Transactionpurchase transaction, it being agreed that the Reviewer shall make each such Representative aware of the confidential nature of the Evaluation Material and shall require each such Representative to treat such Evaluation Material confidentially in accordance with this Agreement. (d) By signing and/or electronically acknowledging this confidentiality Agreement, Reviewer and its representatives understand and agree that there is not a co-broker fee or sharing of Brokerage Fee unless expressly agreed in writing between Broker, Reviewer and/or Reviewer’s Agent.